McKesson and CD&R take Option Care private for $5.8B
Drug distributor McKesson and private equity firm Clayton Dubilier & Rice agreed to take infusion therapy provider Option Care private in a $5.8 billion deal.
Drug distributor McKesson and private equity firm Clayton Dubilier & Rice agreed to take infusion therapy provider Option Care private in a $5.8 billion deal.
Jio Platforms is likely to seek a Rs 11 lakh crore valuation for its IPO and start investor meetings this week.
At the newly announced price band, the NSE IPO is estimated to raise ₹21,494-22,569 crore, significantly lower than the earlier estimate of around ₹30,000 crore.
In 2025, global healthcare private equity hit a record $191 billion in deal value, surpassing the 2021 peak, according to Bain & Company.
Vancouver-based Harbourfront Wealth Group is acquiring Galliant Advisors LP, a Montreal-based investment management firm, marking the company's sixth acquisition in under three years.
The U.S. semiconductor manufacturing equipment market is projected to reach USD 24.83 billion by 2031, driven by CHIPS Act investments, domestic fab installations, and AI demand.
Fitch cited 'materially higher leverage' after the Paramount-Warner Bros. Discovery acquisition and 'significant execution and integration risks' in downgrading both companies.